NUACRES
LIVE

Serial Number

79358612

Owner

Nucleic Acids to the Rescue GmbH

Attorney

Nicholas D. Wells

Filing Date

Nov 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NUACRES Trademark

Serial Number: 79358612 • Registration: 7781043

NUACRES is a trademark filed by Nucleic Acids to the Rescue GmbH on November 7, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Nucleic Acids to the Rescue GmbH (3 trademarks)

Mörfelder Landstr. 112

Entity Type: 16

Gentechnologiestiftung - (3 trademarks)

Troppauer Str. 19a

Entity Type: 12

Burghardt Wittig (3 trademarks)

Salzachstr. 33

Entity Type: 01

Trademark Details

Filing Date

November 7, 2022

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Medical treatments, particularly in the field of oncology and infectiology; medical analysis services related to the treatment of patients, particularly in the field of oncology and infectiology; medical services in connection with the treatment of cancer; medical testing in connection with the diagnosis and treatment of diseases, particularly in the field of oncology and infectiology; medical testing for diagnostic or treatment purposes, particularly in the field of oncology and infectiology; medical treatments based on clinical treatment algorithms, particularly in the field of oncology and infectiology; performance of medical tests related to the diagnosis and treatment of cancer; medical examinations for the diagnosis or treatment of cancer; medical treatments of cancer based on clinical treatment algorithms; medical equipment rental, particularly for computer aided treatments; medical services; pharmaceutical services, namely, monitoring of drug therapy used for cancer and infectious diseases for medical treatment and diagnosis purposes; computer-assisted medical assessment and diagnostical services

Technical services relating to pharmaceutical and medical preparations, pharmaceuticals and drugs, namely, technical research in the field of using computers to diagnose disease and health conditions; provision of information relating to medical and veterinary research and development, particularly in the field of oncology and infectiology; providing an on-line searchable database in the fields of medical and veterinary research and development, particularly in the field of oncology and infectiology; research and development for the pharmaceutical industry, particularly in the field of oncology and infectiology; biomedical research services; research and development services in the field of oncology; research and development services in the field of infectiology; research and development of biomolecules, cells and cellular products for medical use; research and development of biomedical products, particularly therapeutical and prophylactic substances for medical use in the field of oncology and infectiology; research and development in the field of clinical treatment algorithms; medical laboratory services; computer diagnostic services, particularly based on clinical treatment algorithms; computer diagnostic services, particularly in the field of oncology; computer diagnostic services, particularly in the field of infectiology; development of diagnostic apparatus for computer aided medical treatment

Medical and veterinary preparations for the treatment of neoplastic pathologies and infectious diseases; pharmaceuticals, namely, vaccines; biomedical pharmaceutical products for the treatment of neoplastic pathologies and infectious diseases; clinical diagnostic reagents for medical use; therapeutical agent substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies (aptamers); Prophylactical agent substances in the nature of infection prophylactic agents and cancer prophylactic agents; pharmaceutical products, particularly for the field of oncology and infectiology all in the nature of pharmaceutical products for the prevention and treatment of cancer and infectious diseases; biomedical products based on cytological research substances all in the nature of oligo- and poly-nucleotides and nucleic acid antibodies (aptamers); pharmaceuticals, particularly for the use in algorithm supported medical treatment all in the nature of pharmaceuticals for treating of infectious diseases and cancer; chemical or biological substances in the nature of oligo- and poly-nucleotides and nucleotids and nucleic acid antibodies (aptamers) and reagents as part of medical and veterinary preparations; chemical or biological substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies all for the treatment of cancer and infectious diseases and reagents for medical and veterinary use; agonists for medical and veterinary use; TLR agonists for medical and veterinary use; agonists as part of medical and veterinary preparations; TLR agonists as part of medical and veterinary preparations

Chemical or biological substances in the nature of Oligo- and poly-nucleotide arrays for scientific and medical research and reagents for scientific purposes; Chemical or biological substances, namely, molecular constructs made of DNA or RNA to serve as reagents for research in the field of diagnostics; Chemical or biological molecular constructs made of DNA or RNA for scientific or medical research use; Chemicals and chemical preparations for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 11, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 26, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 26, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 6, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 19, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 19, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 19, 2025 COAR
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTICE OF PUBLICATION
Mar 12, 2025 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2025 CNSA
EXAMINERS AMENDMENT -WRITTEN
Feb 25, 2025 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 30, 2024 OPNX
CHANGE OF OWNER RECEIVED FROM IB
Jun 21, 2024 CHLD
CHANGE OF OWNER RECEIVED FROM IB
Jun 14, 2024 CHLD
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2024 OPNR
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 29, 2024 ZZZX
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Apr 19, 2024 PBSR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 7, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 6, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 22, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 31, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 23, 2022 REPR